Agreement between Alzheimer's disease blood biomarkers and clinical diagnosis in primary care
These are the first results of the ongoing CANTATE-PC study. Our findings indicate a high agreement between possible cognitive impairment as indicated by a MoCA score <26 and a syndrome diagnosis of MCI or dementia in primary care, but a low agreement between GPs' etiological diagnosis and abnormal AD blood biomarkers in this group. Our results suggest that AD blood biomarkers may be able to offer additional support to GPs when evaluating the presence of AD.
Authors
- Melchior C. Nierman (ORCID: https://orcid.org/0000-0002-8647-7509)
- Thomas Claessen
- Jurgen Kooren
- Michelle Barboure
- Inge M.W. Verberk
- W. M. van der Flier
- David H Wilson
- Charlotte E. Teunissen
- Argonde C. van Harten
Institutions
- Amsterdam Neuroscience (NL)
- Quanterix (United States) (US)
- Amsterdam University Medical Centers (NL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_105489
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00